Hepatitis B virus infection.
Shayeb
J
J
Department of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Soweid
A
A
D000998:Antiviral Agents / Q000627:therapeutic use; D006509:Hepatitis B / Q000175:diagnosis / Q000628:therapy / Q000635:transmission / Q000821:virology; D006515:Hepatitis B virus / Q000254:growth & development / Q000472:pathogenicity*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D016031:Liver Transplantation; D011379:Prognosis; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine